Screening for suicidal ideation in children with epilepsy.

Area of Science:

• Child and Adolescent Psychiatry
• Neuropsychology
• Public Health

Background:

• The U.S. Food and Drug Administration (FDA) issued a warning regarding a potential link between antiepileptic drugs and suicidal behavior.
• There is a critical need to identify methods for detecting suicidal ideation in pediatric epilepsy populations.

Purpose of the Study:

• To compare the effectiveness of the Child Behavior Checklist (CBCL) and structured psychiatric interviews in detecting suicidal behavior in children with epilepsy.
• To identify reliable predictors of suicidal ideation in this vulnerable group.

Main Methods:

• The study involved 177 children with epilepsy (aged 5-16 years) whose parents completed the CBCL.
• Psychiatric diagnoses were established through structured interviews with children and parents.
• Children were directly interviewed about suicidal behaviors.

Main Results:

• Elevated scores on the CBCL Total Problems scale correctly classified children with suicidal ideation in 79% of cases.
• Having more than one psychiatric diagnosis correctly classified children with suicidal ideation in 80% of cases.
• Both elevated CBCL scores and multiple psychiatric diagnoses were significant predictors of suicidal ideation.

Conclusions:

• The CBCL is a valuable tool for screening and identifying children with epilepsy at risk for suicidal behavior.
• Children with epilepsy and multiple psychiatric diagnoses warrant further assessment for suicidal behavior, regardless of diagnosis type.
• Utilizing parent-completed questionnaires in waiting rooms can aid in early risk identification.